Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Conexeu Sciences announced it raised $30,900 in an initial filing from an offering of $30,900
PUBLIC · CNXUSep 29, 2026
Amount Raised
$30,900
Round Type
Pre-Seed
RenoBiotechnology
Company Information
Company
Conexeu Sciences
Location
Reno, Nevada, United States
About
Conexeu Sciences is a biotechnology company advancing regenerative medicine with its patented collagen flowable gel platform. Emerging from over a decade of University research, Conexeu is developing this groundbreaking technology that could transform wound care, medical aesthetics, and tissue engineering. The company holds patents in the U.S., E.U., Japan, Australia, and pending in Canada, underscoring its global leadership in this innovation.
Fundz sees it the moment Conexeu Sciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
RenoBiotechnology